Forgerini, Marcela 
; Urbano, Gustavo ; Nadai, Tales Rubens de ; Batah, Sabrina Setembre ; Fabro, Alexandre Todorovic ; Mastroianni, Patrícia de Carvalho
Source: Frontiers in Pharmacology. Unidades: FOB, FMRP
Subjects: FARMACOVIGILÂNCIA, POLIMORFISMO, ÚLCERA PÉPTICA, HEMORRAGIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FORGERINI, Marcela et al. Genetic variants in PTGS1 and NOS3 genes increase the risk of upper gastrointestinal bleeding: a case–control study. Frontiers in Pharmacology, v. 12, 2021Tradução . . Disponível em: https://doi.org/10.3389/fphar.2021.671835. Acesso em: 01 nov. 2024.APA
Forgerini, M., Urbano, G., Nadai, T. R. de, Batah, S. S., Fabro, A. T., & Mastroianni, P. de C. (2021). Genetic variants in PTGS1 and NOS3 genes increase the risk of upper gastrointestinal bleeding: a case–control study. Frontiers in Pharmacology, 12. doi:10.3389/fphar.2021.671835NLM
Forgerini M, Urbano G, Nadai TR de, Batah SS, Fabro AT, Mastroianni P de C. Genetic variants in PTGS1 and NOS3 genes increase the risk of upper gastrointestinal bleeding: a case–control study [Internet]. Frontiers in Pharmacology. 2021 ; 12[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2021.671835Vancouver
Forgerini M, Urbano G, Nadai TR de, Batah SS, Fabro AT, Mastroianni P de C. Genetic variants in PTGS1 and NOS3 genes increase the risk of upper gastrointestinal bleeding: a case–control study [Internet]. Frontiers in Pharmacology. 2021 ; 12[citado 2024 nov. 01 ] Available from: https://doi.org/10.3389/fphar.2021.671835
